Desjardins Raises Cameco (CCJ) Price Target to C$105 on Dukovany Project

Cameco Corporation (NYSE:CCJ) is one of the top 10 nuclear energy stocks to invest in for the next decade. On June 17, Desjardins lifted its price target for the company’s stock to C$105.00 from C$85.00 while maintaining a “Buy” rating on the shares. The primary basis for the adjustment was Desjardins’ updated financial model.

Cameco’s price target was raised after analysts updated their models to include a one-time $170 million boost in earnings from Westinghouse Electric’s role in building nuclear reactors at the Dukovany power plant. They also assumed there’s a 50% chance of a similar gain happening in 2026, which helped increase the company’s overall valuation.

Desjardins noted that the uranium sector has experienced recent share price appreciation, with Cameco “leading the group in performance.” As such, the research firm considers Cameco a “go-to name for uranium investors.”

Cameco Corporation (NYSE:CCJ) is a Canadian company that supplies uranium fuel and provides nuclear services for clean electricity generation. It operates through three main segments: Uranium (exploration, mining, and sale of uranium concentrate), Fuel Services (refining, conversion, and fabrication of uranium), and Westinghouse (nuclear reactor technology and services).

While we acknowledge the potential of CCJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Healthcare Penny Stocks to Buy According to Analysts and Goldman Sachs Energy Stocks: 10 Stocks to Buy.

Disclosure: None.